en

PRODUCT DETAIL

Abiraterón Aristo 250 mg tablety

Code 7703D
MA number 44/0150/21-S
Product Form: tbl 120x250 mg (fľ.HDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BX Other hormone antagonists and relate agents
L02BX03 Abiraterone
Shelf life: 30
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 11.06.2021
Validity: 11.06.2026
SPC: SPC_Abiraterón Aristo 250 mg tablety_06.2022.pdf  
PIL: PIL_Abiraterón Aristo 250 mg tablety_06.2022.pdf  
Safety feature Yes
Data update: 14.06.2022
eu-flag.png sk-flag.png